Concerns have been raised that the presence of mifepristone in water supplies could reduce the fertility of the general population.
The Environmental Protection Agency is evaluating the abortion drug mifepristone as a potential water contaminant after 14 state attorneys general requested a water safety review over the pharmaceutical. Health advocates and politicians have increasingly raised the concern that the abortion drug could adversely impact the fertility of the general population.
“Pharmaceuticals, like Mifepristone, encompass a diverse group of chemicals, including prescription and over the counter drugs,” an EPA spokesperson said. “EPA is currently reviewing comments submitted on its draft contaminant candidate list 6 (CCL 6), which lists pharmaceuticals as a group, and human health benchmarks for 374 individual pharmaceuticals that are approved by the FDA and may occur in surface and groundwaters and/or treated drinking water.”
“While EPA cannot predetermine the outcome of its rulemaking, the intent of the draft sixth Candidate Contaminant List is to begin the process of evaluating the occurrence of several contaminant groups, such as pharmaceuticals, in drinking water,“ the agency spokesperson said. EPA’s mission and the intent of the Safe Drinking Water Act is ensuring safe drinking water for the American public.”
As the Lord Leads, Pray with Us…
- For Administrator Zeldin to be discerning as he heads the Environmental Protection Agency.
- For EPA officials as they oversee water testing to determine the risk of the abortion drug’s presence in the nation’s water supply.
Sources: Life News, Center Square, E&E News
